gemfibrozil has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradamante, V; Jasna, L; Kelava, M; Konjevoda, P; Koprivanac, M; Lovric, J; Macan, M; Marija, M; Marijan, K; Marta, K; Nada, V; Paško, K; Vlasta, B; Vrkic, N | 1 |
| Borisov, VV; Ehsani, V; Fatemi, I; Giménez-Llort, L; Hakimizadeh, E; Hassanshahi, J; Kaeidi, A; Khajehasani, F; Movahedinia, S; Zamanian, MY | 1 |
2 other study(ies) available for gemfibrozil and malondialdehyde
| Article | Year |
|---|---|
The influence of gemfibrozil on malondialdehyde level and paraoxonase 1 activity in wistar and fisher rats.
Topics: Animals; Aryldialkylphosphatase; Gemfibrozil; Heart; Hydrogen Peroxide; Hypolipidemic Agents; Kidney; Lipid Peroxidation; Lipid Peroxides; Liver; Male; Malondialdehyde; Peroxisomes; Rats; Rats, Inbred F344; Rats, Wistar | 2011 |
Gemfibrozil, a lipid-lowering drug, reduces anxiety, enhances memory, and improves brain oxidative stress in d-galactose-induced aging mice.
Topics: Aging; Animals; Antioxidants; Anxiety; Brain; Eosine Yellowish-(YS); Galactose; Gemfibrozil; Hematoxylin; Hypolipidemic Agents; Male; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress; Superoxide Dismutase | 2022 |